Company: TELO
Filing Date: 2025-02-04
Form Type: 10-K
Source: 0001493152-25-004872
Chunk: 422

Company: Telomir Pharmaceuticals, Inc.
Filing Date: 2025-02-04
Form: 10-K
Item: Item 1A
Chunk 422
---
 devotes part of his working time to other business endeavors and may have responsibilities to other
entities. Although Mr. Aminov is aware of his duties and accountability to our company and to applicable laws and policies relating to
corporate opportunity and conflicts of interest, such conflicts of interest may include deciding how much time to devote to our affairs,
as well as what business opportunities should be presented to us.

Michelle
Yanez, our Chief Financial Officer, is not employed by our company on a full-time basis. As intended to be provided in her employment
agreement with our company, she works on a part-time and as-needed basis. Because she does not work full time for our company, instances
may occur where she may not be immediately available to provide solutions to problems or address concerns that arise in the course of
us conducting our business and thus adversely affect our business. In addition, she can become subject to conflicts of interest because
she devotes part of her working time to other business endeavors and may have responsibilities to other entities. Although Mrs. Yanez
is aware of her duties and accountability to our company and to applicable laws and policies relating to corporate opportunity and conflicts
of interest, such conflicts of interest may include deciding how much time to devote to our affairs, as well as what business opportunities
should be presented to us.

Conflicts
of interest may arise between us and MIRALOGX.

MIRALOGX
has a non-provisional patent application to the rights to Telomir-1. MIRALOGX is a separate intellectual property development company
owned by the Bay Shore Trust, which is an irrevocable trust established by our founder, Jonnie R. Williams, Sr., and in which Brian McNulty
is the trustee. The Bay Shore Trust is also our largest stockholder. We have an exclusive license from MIRALOGX to develop and commercialize
Telomir-1 in the U.S. for human and non-human applications. Although the interests of MIRALOGX are 100% owned by the Bay Shore Trust,
and Mr. Williams is not an officer or director of MIRALOGX and Mr. Williams does not have voting or dispositive power over the shares
of our company held by Bay Shore Trust, our relationship with the Bay Shore Trust, Mr. Williams may create, or may create the appearance
of, conflicts of interest when we are faced with decisions that could have different implications for MIRALOG